We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Hypothermia Treatment Helps Cardiac Arrest Victims

By HospiMedica International staff writers
Posted on 01 Dec 2015
A new study reveals that therapeutic hypothermia (TH) improves survival and neurological outcomes after cardiac arrest in patients with initially non-shockable rhythms.

Researchers at Thomas Jefferson University (Philadelphia, PA, USA), the University of Colorado School of Medicine (Aurora, USA; medschool.ucdenver.edu), and other institutions conducted a retrospective cohort study involving 519 post cardiac-arrest patients with initial non-shockable rhythms to determine whether TH improved their neurologic outcome and survival. More...
Patient and arrest characteristics were used to estimate the propensity to receive TH, including age, sex, location and duration of arrest, and if the arrest was witnessed. To determine the association between TH and outcomes, 201 propensity score matched pairs were compared.

The results showed that TH patients were significantly younger, had longer durations of arrest, and had a higher incidence of asystole as their primary rhythm. Survival to hospital discharge was higher after TH (29%) than after not receiving TH (15%), and cerebral performance was significantly higher for patients who underwent TH (21%) than for patients who did not undergo TH (10%). In all, TH was associated with a 3.5-fold increased likelihood of favorable neurological outcome and 2.8-fold increased likelihood of survival to hospital discharge. The study was published on November 16, 2015, in Circulation.

“Our findings provide further support for the use of TH in patients with initial nonshockable rhythms, given the lack of randomized controlled trial data, and should encourage its use in this patient population while awaiting data from randomized trials,” concluded lead author Sarah Perman, MD, of Thomas Jefferson University, and colleagues. “Regardless of the location of the cardiac arrest, patients who underwent TH were significantly more likely than those who did not receive TH to survive to hospital discharge neurologically intact.”

Therapeutic cooling is among the most potent interventions for hypoxic-ischemic injury, a broad constellation of conditions ranging from cardiac and respiratory arrest to carbon monoxide (CO) and other poisonous gas exposure, and appears to limit tissue damage by reducing oxygen metabolism and inflammation, while maintaining cell membrane integrity. Other studies have shown that HT after cardiac arrest increases patients’ chances of survival by 31% and quality of survival by 41%.

Related Links:

Thomas Jefferson University
University of Colorado School of Medicine



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.